Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo.
Low density lipoprotein modified by oxidation (Ox-LDL) causes adhesion of leukocytes to the endothelium, a feature common in early atherogenesis. Because leukocyte adhesion under various pathophysiological conditions involves superoxide generation, we explored the possibility that superoxide is likewise involved in leukocyte adhesion in response to Ox-LDL. For our studies, we used the dorsal skin fold chamber model for intravital microscopic observation of leukocyte-endothelium interactions in hamsters. We show here that injection of human LDL (4 mg/kg LDL cholesterol oxidatively modified by incubation in 7.5 microM Cu2+ for 18 hours at 37 degrees C) elicited in control hamsters (n = 7) the rolling and adhesion of circulating leukocytes along the endothelium of arterioles and postcapillary venules. This adhesion was significantly attenuated when hamsters were pretreated with bovine copper-zinc-superoxide dismutase (CuZn-SOD, 0.25 mg/kg, n = 7) or heparin (2,000 IU/kg, n = 7). The CuZn-SOD infusion and the heparin-induced release of extracellular SOD from endothelial cell surfaces to plasma resulted in nearly equal plasma SOD activities. Further inhibition of Ox-LDL-induced leukocyte adhesion could not be achieved by increasing the dose of CuZn-SOD to 5 mg/kg (n = 6). Pretreatment of the hamsters with inactivated CuZn-SOD showed no effect. These results indicate that Ox-LDL stimulates leukocyte adhesion through a superoxide-dependent step, and they indicate a possible mechanism by which antioxidants might inhibit the onset of experimental and clinical atherosclerosis.
Lehr
H A
HA
Institute for Surgical Research, University of Munich, FRG.
Becker
M
M
Marklund
S L
SL
Hübner
C
C
Arfors
K E
KE
Kohlschütter
A
A
Messmer
K
K
D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D006224:Cricetinae; D004912:Erythrocytes / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood; D007962:Leukocytes / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects; D013482:Superoxide Dismutase / Q000097:blood / Q000502:physiology*
D005227:Fatty Acids; D008055:Lipids; D008077:Lipoproteins, LDL; D013482:Superoxide Dismutase